Leung L Stan, Canning Kevin J, Shen Bixia
Department of Physiology-Pharmacology, University of Western Ontario, London, Ontario, Canada.
Epilepsia. 2005 Feb;46(2):203-16. doi: 10.1111/j.0013-9580.2005.35804.x.
To determine whether hippocampal afterdischarges (ADs) and excitability changes were induced by gamma-aminobutyric acid (GABA)(B)-receptor blockade in adult, freely moving rats.
A specific GABA(B)-receptor antagonist CGP35348, CGP55845A, or CGP55699A was injected intracerebroventricularly (i.c.v.), and EEGs and behaviors of rats were analyzed.
CGP35348 (56-110 microg, i.c.v.) induced afterdischarges (ADs) approximately 60% of the time, starting at the hippocampus or neocortex. Neocortical-onset ADs began with sporadic discharges and were <3 mV. Hippocampal-onset ADs were bilateral, >5 mV, and spread to the entorhinal cortex and amygdala, often ending in a rebound AD and accompanied with stereotypic jumping, forelimb clonus, and wet-dog shakes. The CGP35348-induced hippocampal AD had an onset frequency (5-9 Hz) that was higher than the electrically evoked AD (2-4 Hz). CGP35348 i.c.v. also increased the mean starting frequency of an electrically evoked hippocampal AD from 3.6 Hz to 5.3 Hz. Hippocampal gamma activity (25-80 Hz) increased up to twofold for 30 min after a hippocampal but not a neocortical AD. A single dose of CGP35348 induced repeated ADs of increasing duration. Paired-pulse inhibition of the evoked potentials in CA1, at interpulse interval of <100 ms, was decreased after but not before a hippocampal AD. CGP56999A (i.c.v.) gave results similar to those with CGP35348, whereas CGP55845A (i.c.v.) rarely induced ADs.
GABA(B)-receptor blockade increases seizure susceptibility by reducing AD threshold and increasing the frequency and spread of a hippocampal AD. Hippocampal excitability (based on paired-pulse test) and gamma activity increased after but not before a hippocampal AD.
确定在成年自由活动大鼠中,γ-氨基丁酸(GABA)(B)受体阻断是否会诱发海马后放电(ADs)和兴奋性变化。
将特异性GABA(B)受体拮抗剂CGP35348、CGP55845A或CGP55699A脑室内注射(i.c.v.),并分析大鼠的脑电图和行为。
CGP35348(56 - 110微克,i.c.v.)约60%的时间会诱发后放电(ADs),起始于海马或新皮层。新皮层起始的ADs始于散在放电,且小于3毫伏。海马起始的ADs是双侧性的,大于5毫伏,并扩散至内嗅皮层和杏仁核,常以反弹AD结束,并伴有刻板跳跃、前肢阵挛和湿狗样抖动。CGP35348诱发的海马AD起始频率(5 - 9赫兹)高于电诱发的AD(2 - 4赫兹)。CGP35348 i.c.v.还使电诱发海马AD的平均起始频率从3.6赫兹增加到5.3赫兹。海马AD后而非新皮层AD后,海马γ活动(25 - 80赫兹)在30分钟内增加至两倍。单次注射CGP35348会诱发持续时间增加的反复ADs。海马AD后而非之前,在脉冲间隔小于100毫秒时,CA1区诱发电位的配对脉冲抑制降低。CGP56999A(i.c.v.)的结果与CGP35348相似,而CGP55845A(i.c.v.)很少诱发ADs。
GABA(B)受体阻断通过降低AD阈值、增加海马AD的频率和扩散来增加癫痫易感性。海马兴奋性(基于配对脉冲试验)和γ活动在海马AD后而非之前增加。